IU School of Medicine studying potential coronavirus treatments


FILE – In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

IU School of Medicine is awaiting results of two clinical trials for the drug remdesivir as they study potential treatments for COVID-19.

One trial focused on patients who need supplemental oxygen. Researchers are studying if a five-day remdesivir treatment worked as well as a ten-day treatment. The second trial studied the impact of remdesivir on hospital patients who didn’t require supplemental oxygen.

Other trials of the drug have shown some positive results, giving hope to many that the virus is treatable.

“It may very well be similar to other infectious diseases where we know that certain therapies are important for people early, and then certain therapies are more important later, or maybe you combine the treatments.”

Dr. Samir Gupta, Vice Chair for Research, Department of Medicine, Indiana University School of Medicine

Both trials have been completed and results are expected to be back by the end of May.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Most Popular

Indy Now

Latest News

More News